Medicines and Healthcare products Regulatory Agency

MANUFACTURER'S AUTHORISATION
1: Authorisation Number UK MIA(IMP) 43086
2: Name of authorisation holder TARGET HEALTHCARE LIMITED
3: Address(es) of manufacturing site(s)

TARGET HEALTHCARE LIMITED, QUANTUM HOUSE, HOBSON INDUSTRIAL ESTATE, HOBSON, NEWCASTLE UPON TYNE, NE16 6EA, UNITED KINGDOM

4: Legally registered address of authorisation holder TARGET HEALTHCARE LIMITED, QUANTUM HOUSE, HOBSON INDUSTRIAL ESTATE, HOBSON, NEWCASTLE UPON TYNE, NE16 6EA, UNITED KINGDOM
5: Scope of authorisation and dosage forms ANNEX 1 and/ or ANNEX 2
6: Legal Basis of authorisation
7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation Confidential
8: Authorisation Date 06/12/2023
9: Annexes attached Annex 1 and/or Annex 2
SCOPE OF AUTHORISATION
Annex 2
Name and address of the site:

TARGET HEALTHCARE LIMITED, QUANTUM HOUSE, HOBSON INDUSTRIAL ESTATE, HOBSON, NEWCASTLE UPON TYNE, NE16 6EA, UNITED KINGDOM

Human Investigational Medicinal Products
Authorised Operations
Authorised Operations
MANUFACTURING OPERATIONS (according to part 1)
Operations
Part 1 - MANUFACTURING OPERATIONS
[ 1.1 ] Sterile Investigational Medicinal Products
    [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms)
        [ 1.1.1.4 ] Small volume liquids
        [ 1.1.1.6 ] Other aseptically prepared products
            Schedule 2 controlled substances, Cytotoxics (chemotherapy), Monoclonal antibodies
    [ 1.1.3 ] Batch certification
[ 1.2 ] Non-sterile investigational medicinal products
    [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms)
        [ 1.2.1.6 ] Liquids for internal use
        [ 1.2.1.9 ] Pressurised preparations
        [ 1.2.1.15 ] Other non-sterile medicinal products
            Cannabidiol products
    [ 1.2.2 ] Batch certification
[ 1.3 ] Biological investigational medicinal products
    [ 1.3.1 ] Biological medicinal products
        [ 1.3.1.2 ] Immunological products
    [ 1.3.2 ] Batch certification
        [ 1.3.2.2 ] Immunological products
[ 1.5 ] Packaging
    [ 1.5.1 ] Primary packaging
        [ 1.5.1.6 ] Liquids for internal use
        [ 1.5.1.9 ] Pressurised preparations
    [ 1.5.2 ] Secondary packaging
[ 1.6 ] Quality control testing
    [ 1.6.1 ] Microbiological: sterility
    [ 1.6.2 ] Microbiological: non-sterility
    [ 1.6.3 ] Chemical/Physical
    [ 1.6.4 ] Biological